[HTML][HTML] Cost effectiveness of patient self-managed warfarin compared with direct oral anticoagulants in atrial fibrillation: an economic evaluation in a Danish …
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
[HTML][HTML] Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish …
SM Raunbak, AS Sørensen, L Hansen… - PharmacoEconomics …, 2022 - ncbi.nlm.nih.gov
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare …
SM Raunbak, AS Sørensen… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare …
SM Raunbak, AS Sørensen, L Hansen… - …, 2022 - search.proquest.com
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare …
SM Raunbak, AS Sørensen, L Hansen… - …, 2022 - econpapers.repec.org
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare …
SM Raunbak, AS Sørensen, L Hansen… - Pharmacoeconomics …, 2022 - europepmc.org
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare …
SM Raunbak, AS Sørensen, L Hansen… - PharmacoEconomics …, 2022 - ideas.repec.org
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
Cost Effectiveness of Patient Self‑Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare …
SM Raunbak, AS Vestergaard, L Hansen… - PharmacoEconomics …, 2022 - vbn.aau.dk
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare …
SM Raunbak, AS Sørensen, L Hansen… - Pharmacoeconomics …, 2022 - europepmc.org
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
[PDF][PDF] Cost Effectiveness of Patient Self‑Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish …
SM Raunbak, AS Sørensen, L Hansen, F Skjøth… - 2022 - vbn.aau.dk
Background Patient self-managed anticoagulant treatment with warfarin (PSM) has been
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …
proposed as an alternative to direct oral anticoagulants (DOACs) in patients with non …